MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers17132143

Медицинская библиотека · Cancers · 2025

The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions.

Semenova Yuliya, Burkitbayev Zhandos, Kalibekov Nurtas, Digay Alexandr, Zhaxybayev Bakhyt, Shatkovskaya Oxana, Khamzina Saule, Zharlyganova Dinara, Kuanysh Zhuldyz, Manatova Almira

СтатьяОбзорПеревод в очереди

Аннотация

Pleural malignancies represent a clinically devastating group of oncological disorders, most commonly arising from metastatic disease, with lung and breast cancers being the most frequent primary sites. Malignant pleural mesothelioma is a primary malignancy of the pleura and occurs less often than metastatic pleural disease. Pleural malignancies often present with malignant pleural effusion, which typically indicates advanced-stage disease and is associated with poor overall prognosis. Treatment of pleural malignancies includes both palliative and definitive approaches. Palliative interventions primarily aim to relieve symptoms and improve quality of life. Definitive treatments include systemic chemotherapy, targeted therapy, and immunotherapy, depending on the type and molecular profile of the underlying tumor. In mesothelioma, platinum-based chemotherapy in combination with pemetrexed remains the cornerstone of treatment, while the combination of nivolumab and ipilimumab is recommended as first-line therapy for unresectable disease. For metastatic disease, systemic therapy is typically tailored to the primary tumor's characteristics. Intrapleural administration of chemotherapeutic agents is one of the therapeutic strategies and hyperthermic intrathoracic chemotherapy and pressurized intrathoracic aerosol chemotherapy are the most recent innovations that are under active investigation. This review provides an up-to-date synthesis of systemic chemotherapy strategies for pleural malignancies, their integration with targeted and immune-based therapies, and recent advances in intrapleural chemotherapy modalities. It also explores existing knowledge gaps and outlines directions for future research and potential changes in clinical practice.

Для цитирования: Semenova Yuliya, Burkitbayev Zhandos, Kalibekov Nurtas, Digay Alexandr, Zhaxybayev Bakhyt, Shatkovskaya Oxana, Khamzina Saule, Zharlyganova Dinara, Kuanysh Zhuldyz, Manatova Almira. The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions.. Cancers. 2025. DOI: 10.3390/cancers17132143.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.